All Resources

This page provides filters and search facilities across all types of CF resources contained within the ECFS website.

Additionally, you can visit the specific resource type pages as follows:

More information on CF publications can be found here: Publications

October 2022

Title: Long-term bone mineral density changes and fractures in lung transplant recipients with cystic fibrosis
References
J Cyst Fibros. 2020 Oct; 21  2020DOI:https://doi.org/10.1016/j.jcf.2020.09.012

January 2021

Title: ACT with CF: A telehealth and in-person feasibility study to address anxiety and depressive symptoms among people with cystic fibrosis
References
J Cyst Fibros. 2021 Jan;20(1):133-139. doi: 10.1016/j.jcf.2020.11.013. Epub 2020 Dec 2.

January 2021

Title: Changes in airway inflammation with pseudomonas eradication in early cystic fibrosis
References
J Cyst Fibros . 2021 Jan 15;S1569-1993(20)30947-4. doi: 10.1016/j.jcf.2020.12.015. 

January 2021

Title: Designing the GALAXY study: Partnering with the cystic fibrosis community to optimize assessment of gastrointestinal symptoms
References
J Cyst Fibros. 2021 Jan 12;S1569-1993(20)30953-X. doi: 10.1016/j.jcf.2020.12.021. 

December 2020

Title: Pilot study suggests that the gut bacteria in people with CF change with CFTR modulator therapy
References
J Cyst Fibros. 2020 Dec 31;S1569-1993(20)30934-6. doi: 10.1016/j.jcf.2020.12.002. 

December 2020

Title: Men's health in the modern era of cystic fibrosis
References
J Cyst Fibros. 2020 Dec 26;S1569-1993(20)30945-0. doi: 10.1016/j.jcf.2020.12.013. 

December 2020

Title: Psychological distress in adults with and without cystic fibrosis during the COVID-19 lockdown
References
J Cyst Fibros. 2020 Dec 23;S1569-1993(20)30948-6. doi: 10.1016/j.jcf.2020.12.016. 

December 2020

Title: Assessing the effect of adding chelating agent (Tris-CaEDTA) to nebulised tobramycin for improving bacterial killing and lung function in cystic fibrosis patients with Pseudomonas aeruginosa lung infection.
References
J Cyst Fibros. 2020 Dec 16;S1569-1993(20)30936-X. doi: 10.1016/j.jcf.2020.12.004.
Title: Ototoxicity in Cystic Fibrosis Patients Receiving Intravenous Tobramycin for Acute Pulmonary Exacerbation
References
J Cyst Fibros. 2020 Dec 16;S1569-1993(20)30930-9. doi: 10.1016/j.jcf.2020.11.020.

December 2020

Title: The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network
References
J Cyst Fibros. 2020 Dec 15;S1569-1993(20)30939-5. doi: 10.1016/j.jcf.2020.12.007.
Title: A phase 3, randomized, double-blind, parallel-group study to evaluate tezacaftor/ivacaftor in people with cystic fibrosis heterozygous
References
J Cyst Fibros. 2020 Dec 15;S1569-1993(20)30906-1. doi: 10.1016/j.jcf.2020.11.003.

December 2020

Title: Impact of biofilm formation and azoles' susceptibility in Scedosporium/Lomentospora species using an in vitro model that mimics the cystic fibrosis patients' airway environment
References
J Cyst Fibros. 2020 Dec 14;S1569-1993(20)30933-4. doi: 10.1016/j.jcf.2020.12.001.

December 2020

Title: Environmental risks of Pseudomonas aeruginosa-What to advise patients and parents
References
J Cyst Fibros. 2020 Dec 12;S1569-1993(20)30937-1. doi: 10.1016/j.jcf.2020.12.005. Online ahead of print.

December 2020

Title: Organoids for personalized treatment of Cystic Fibrosis: Professional perspectives on the ethics and governance of organoid biobanking
References
J Cyst Fibros. 2020 Dec 7;S1569-1993(20)30921-8. doi: 10.1016/j.jcf.2020.11.015.

December 2020

Title: Sensitive structural and functional measurements and 1-year pulmonary outcomes in pediatric cystic fibrosis
References
J Cyst Fibros. 2020 Dec 4;S1569-1993(20)30929-2. doi: 10.1016/j.jcf.2020.11.019. 

December 2020

Title: CFTR plays an important role in the regulation of vascular resistance and high-fructose/salt-diet induced hypertension in mice
References
J Cyst Fibros. 2020 Dec 2;S1569-1993(20)30920-6. doi: 10.1016/j.jcf.2020.11.014.

November 2020

Title: Prostaglandin E2 and phagocytosis of inhaled particulate matter by airway macrophages in cystic fibrosis
References
J Cyst Fibros. 2020 Nov 26;S1569-1993(20)30913-9. doi: 10.1016/j.jcf.2020.11.010.

November 2020

Title: Long term clinical effectiveness of ivacaftor in people with the G551D CFTR mutation
References
J Cyst Fibros. 2020 Nov 25;S1569-1993(20)30911-5. doi: 10.1016/j.jcf.2020.11.008. 
Title: Lumacaftor/ivacaftor in people with cystic fibrosis with an A455E-CFTR mutation
References
J Cyst Fibros. 2020 Nov 25;S1569-1993(20)30910-3. doi: 10.1016/j.jcf.2020.11.007.

November 2020

Title: Defective immunometabolism pathways in cystic fibrosis macrophages
References
J Cyst Fibros. 2020 Nov 15;S1569-1993(20)30880-8. doi: 10.1016/j.jcf.2020.10.006.

November 2020

Title: Airway epithelial stem cell chimerism in cystic fibrosis lung transplant recipients
References
J Cyst Fibros. 2020 Nov 10;S1569-1993(20)30881-X. doi: 10.1016/j.jcf.2020.09.013.

November 2020

Title: The global impact of SARS-CoV-2 in 181 people with cystic fibrosis
References
J Cyst Fibros. 2020 Nov 4;S1569-1993(20)30877-8. doi: 10.1016/j.jcf.2020.10.003

October 2020

Title: Prospective longitudinal association between repeated multiple breath washout measurements and computed tomography scores in children with cystic fibrosis
References
J Cyst Fibros. 2020 Oct 4;2121. doi: 10.1016/j.jcf.2020.09.010. 

October 2020

Title: Tobacco smoke exposure limits the therapeutic benefit of tezacaftor/ivacaftor in pediatric patients with cystic fibrosis
References
J Cyst Fibros. 2020 Oct 3;S1569-1993(20)30870-5. doi: 10.1016/j.jcf.2020.09.011. Online ahead of print.

September 2020

Title: Safety and Efficacy of Lenabasum in a Phase 2 Randomized, Placebo-Controlled Trial in Adults with Cystic Fibrosis
References
J Cyst Fibros. 2020 Sep 30;S1569-1993(20)30873-0. doi: 10.1016/j.jcf.2020.09.008.

September 2020

Title: Evidence of early increased sialylation of airway mucins and defective mucociliary clearance in CFTR-/- deficient piglets
References
J Cyst Fibros. 2020 Sep 23;S1569-1993(20)30868-7. doi: 10.1016/j.jcf.2020.09.009.

September 2020

Title: A phase 3, double-blind, parallel-group study to evaluate the efficacy and safety of tezacaftor in combination with ivacaftor in participants 6 through 11 years of age with cystic fibrosis homozygous for F508del or heterozygous for the F508del-CFTR mutati
References
J Cyst Fibros . 2020 Sep 21;S1569-1993(20)30811-0. doi: 10.1016/j.jcf.2020.07.023.

September 2020

Title: Anti-inflammatory effects of lenabasum, a cannabinoid receptor type 2 agonist, on macrophages from cystic fibrosis
References
J Cyst Fibros. 2020 Sep;19(5):823-829. doi: 10.1016/j.jcf.2020.03.015. Epub 2020 May 6. 

September 2020

Title: What is the value of lung function testing in infants with cystic fibrosis?
References
 J Cyst Fibros. 2020 Sep 17;S1569-1993(20)30867-5. doi: 10.1016/j.jcf.2020.09.005. Online ahead of print.

September 2020

Title: Trends in nontuberculous mycobacteria infection in children and young people with cystic fibrosis
References
J Cyst Fibros. 2020 Sep 16;S1569-1993(20)30872-9. doi: 10.1016/j.jcf.2020.09.007.

September 2020

Title: Sputum for viral diagnosis in cystic fibrosis patients
References
J Cyst Fibros. 2020 Sep 14;S1569-1993(20)30865-1. doi: 10.1016/j.jcf.2020.09.003.

September 2020

Title: Delayed glucose peak and elevated 1-hour glucose on the oral glucose tolerance test identify youth with cystic fibrosis with lower oral disposition index
References
J Cyst Fibros. 2020 Sep 11;2111. doi: 10.1016/j.jcf.2020.08.020. Online ahead of print.
Title: Delayed glucose peak and elevated 1-hour glucose on the oral glucose tolerance test identify youth with cystic fibrosis with lower oral disposition index
References
J Cyst Fibros. 2020 Sep 11;2111. doi: 10.1016/j.jcf.2020.08.020. Online ahead of print.

September 2020

Title: Baseline CF disease severity has an adverse impact on pregnancy and infant outcomes, but does not impact disease progression
References
J Cyst Fibros. 2020 Sep 9;S1569-1993(20)30864-X. doi: 10.1016/j.jcf.2020.09.002.

September 2020

Title: Lumacaftor/ivacaftor therapy fails to increase insulin secretion in F508del/F508del CF patients
References
J Cyst Fibros. 2020 Sep 8;S1569-1993(20)30862-6. doi: 10.1016/j.jcf.2020.09.001. 

September 2020

Title: Factors influencing clinical trial participation for adult and pediatric patients with cystic fibrosis
References
J Cyst Fibros. 2020 Sep 5;S1569-1993(20)30857-2. doi: 10.1016/j.jcf.2020.08.019. Online ahead of print.

September 2020

Title: Aerosolized lancovutide in adolescents (≥12 years) and adults with cystic fibrosis - a randomized trial
References
J Cyst Fibros. 2020 Sep 1;S1569-1993(20)30830-4. doi: 10.1016/j.jcf.2020.08.014.

August 2020

Title: Immune response of polarized cystic fibrosis airway epithelial cells infected with Influenza A virus
References
J Cyst Fibros. 2020 Aug 29;S1569-1993(20)30827-4. doi: 10.1016/j.jcf.2020.08.012. Online ahead of print.

August 2020

Title: Recommended shielding against COVID-19 impacts physical activity levels in adults with cystic fibrosis
References
J Cyst Fibros. 2020 Aug 28;S1569-1993(20)30828-6. doi: 10.1016/j.jcf.2020.08.013

August 2020

Title: Extensive CFTR sequencing through NGS in Brazilian individuals with cystic fibrosis: unravelling regional discrepancies in the country
References
J Cyst Fibros. 2020 Aug 17;S1569-1993(20)30822-5. doi: 10.1016/j.jcf.2020.08.007.

August 2020

Title: The implementation of an aminoglycoside induced ototoxicity algorithm for people with cystic fibrosis
References
J Cyst Fibros. 2020 Aug 15;S1569-1993(20)30817-1. doi: 10.1016/j.jcf.2020.08.002. Online ahead of print.

August 2020

Title: Long-term safety study of colistimethate sodium (Colobreathe®): Findings from the UK Cystic Fibrosis Registry
References
J Cyst Fibros. 2020 Aug 14;S1569-1993(20)30816-X. doi: 10.1016/j.jcf.2020.08.001. Online ahead of print.

August 2020

Title: Changes in symptom scores as a potential clinical endpoint for studies of cystic fibrosis pulmonary exacerbation treatment
References
J Cyst Fibros. 2020 Aug 13;S1569-1993(20)30820-1. doi: 10.1016/j.jcf.2020.08.006. Online ahead of print.

August 2020

Title: Decreased survival in cystic fibrosis patients with a positive screen for depression
References
J Cyst Fibros. 2020 Aug 12;S1569-1993(20)30812-2. doi: 10.1016/j.jcf.2020.07.020.

August 2020

Title: SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis
References
J Cyst Fibros. 2020 Aug 11;S1569-1993(20)30821-3. doi: 10.1016/j.jcf.2020.08.005

August 2020

Title: Screening for Nontuberculous mycobacteria (NTM) in people with Cystic Fibrosis
References
J Cyst Fibros. 2020 Aug; 9

August 2020

Title: Projecting the impact of delayed access to elexacaftor/tezacaftor/ivacaftor for people with Cystic Fibrosis
References
J Cyst Fibros. 2020 Aug 5;S1569-1993(20)30809-2. doi: 10.1016/j.jcf.2020.07.017. Online ahead of print.

August 2020

Title: Azithromycin and Tezacaftor/Ivacaftor is associated with first-degree heart block in an adult with Cystic Fibrosis
References
J Cyst Fibros. 2020 Aug 4;S1569-1993(20)30808-0. doi: 10.1016/j.jcf.2020.07.016. Online ahead of print.

August 2020

Title: Heat acclimation improves sweat gland function and lowers sweat sodium concentration in an adult with cystic fibrosis
References
J Cyst Fibros. 2020 Aug 2;S1569-1993(20)30804-3. doi: 10.1016/j.jcf.2020.07.013.

July 2020

Title: Clinical characteristics and outcomes associated with Inquilinus infection in cystic fibrosis
References
J Cyst Fibros. 2020 Jul 31;S1569-1993(20)30803-1. doi: 10.1016/j.jcf.2020.07.011. Online ahead of print.
Title: The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and children
References
J Cyst Fibros. 2020 Jul 31;S1569-1993(20)30815-8. doi: 10.1016/j.jcf.2020.07.022. Online ahead of print.

July 2020

Title: Biliary disease and cholecystectomy after initiation of elexacaftor/ivacaftor/tezacaftor in adults with cystic fibrosis
References
J Cyst Fibros. 2020 Jul 29;S1569-1993(20)30806-7. doi: 10.1016/j.jcf.2020.07.014.

July 2020

Title: Developing Innovative GastroEnterology Specialty Training: the DIGEST model for expanding cystic fibrosis gastroenterologic expertise
References
J Cyst Fibros. 2020 Jul 28;S1569-1993(20)30805-5. doi: 10.1016/j.jcf.2020.07.012.

July 2020

Title: Citrullination of extracellular histone H3.1 reduces antibacterial activity and exacerbates its proteolytic degradation
References
J Cyst Fibros. 2020 Jul 26;S1569-1993(20)30802-X. doi: 10.1016/j.jcf.2020.07.010. Online ahead of print.

July 2020

Title: Prospective cohort study of ototoxicity in persons with cystic fibrosis following a single course of intravenous tobramycin
References
J Cyst Fibros . 2020 Jul 23;S1569-1993(20)30793-1. doi: 10.1016/j.jcf.2020.07.001. Online ahead of print.

July 2020

Title: Screening practices for nontuberculous mycobacteria at US cystic fibrosis centers
References
J Cyst Fibros. 2020 Jul;19(4):569-574. doi: 10.1016/j.jcf.2020.02.013. Epub 2020 Mar 13.

July 2020

Title: Effect of highly effective modulator treatment on sinonasal symptoms in cystic fibrosis
References
J Cyst Fibros. 2020 Jul 18;S1569-1993(20)30794-3. doi: 10.1016/j.jcf.2020.07.002.

July 2020

Title: Evaluating assumptions of definition-based pulmonary exacerbation endpoints in cystic fibrosis clinical trials
References
J Cyst Fibros. 2020 Jul 15;S1569-1993(20)30800-6. doi: 10.1016/j.jcf.2020.07.008.
 

July 2020

Title: Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: the international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF)
References
J Cyst Fibros. 2020 Jul;19(4):595-601. doi: 10.1016/j.jcf.2020.01.007. Epub 2020 Jan 23.
Title: CFTR modulator therapy for cystic fibrosis caused by the rare c.3700A>G mutation
References
J Cyst Fibros . 2020 Jul 14;S1569-1993(20)30795-5. doi: 10.1016/j.jcf.2020.07.003.

July 2020

Title: A four week trial of hypertonic saline in children with mild cystic fibrosis lung disease: Effect on mucociliary clearance and clinical outcomes
References
J Cyst Fibros. 2020 Jul 12;S1569-1993(20)30801-8. doi: 10.1016/j.jcf.2020.07.009.

July 2020

Title: Evaluation of airway and circulating inflammatory biomarkers for cystic fibrosis drug development
References
J Cyst Fibros . 2020 Jul 1;S1569-1993(20)30782-7. doi: 10.1016/j.jcf.2020.06.017.

June 2020

Title: A disruption of innervation around CF tissues results in low amount of VIP before CF disease has produced damage to the lungs and small intestine.
References
J Cyst Fibros. 2020 Jun 26;S1569-1993(20)30777-3. doi: 10.1016/j.jcf.2020.06.013. Online ahead of print

June 2020

Title: Fibrocyte accumulation in the lungs of cystic fibrosis patients
References
J Cyst Fibros. 2020 Jun 24;S1569-1993(20)30756-6. doi: 10.1016/j.jcf.2020.06.011. Online ahead of print.

June 2020

Title: Tezacaftor/ivacaftor in people with cystic fibrosis who stopped lumacaftor/ivacaftor due to respiratory adverse events
References
J Cyst Fibros. 2020 Jun 23;S1569-1993(20)30730-X. doi: 10.1016/j.jcf.2020.06.001.
Title: Clinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung function
References
J Cyst Fibros. 2020 Jun 23;S1569-1993(20)30752-9. doi: 10.1016/j.jcf.2020.06.012. Online ahead of print.

June 2020

Title: Lumacaftor/ivacaftor improves liver cholesterol metabolism but does not influence hypocholesterolemia in patients with cystic fibrosis
References
J Cyst Fibros. 2020 Jun 22;S1569-1993(20)30779-7. doi: 10.1016/j.jcf.2020.06.015. Online ahead of print

June 2020

Title: Influenza B outbreak at an adult cystic fibrosis centre - clinical impact and factors influencing spread
References
J Cyst Fibros. 2020 Jun 19;S1569-1993(20)30124-7. doi: 10.1016/j.jcf.2020.04.011.

June 2020

Title: In vitro 3D culture lung model from expanded primary cystic fibrosis human airway cells
References
J Cyst Fibros. 2020 Jun 18;S1569-1993(20)30151-X. doi: 10.1016/j.jcf.2020.05.007. Online ahead of print.

June 2020

Title: Antimicrobial resistance: concerns of healthcare providers and people with CF
References
J Cyst Fibros . 2020 Jun 17;S1569-1993(20)30159-4. doi: 10.1016/j.jcf.2020.05.009

June 2020

Title: Postprandial changes in gastrointestinal function and transit in cystic fibrosis assessed by Magnetic Resonance Imaging
References
J Cyst Fibros. 2020 Jun 16;S1569-1993(20)30733-5. doi: 10.1016/j.jcf.2020.06.004.

June 2020

Title: Newborn screening alone insufficient to improve pulmonary outcomes for cystic fibrosis
References
J Cyst Fibros . 2020 Jun 13;S1569-1993(20)30731-1. doi: 10.1016/j.jcf.2020.06.002. 
Title: The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis
References
J Cyst Fibros. 2020 Jun 13;S1569-1993(20)30163-6. doi: 10.1016/j.jcf.2020.05.013.
Title: Immunotyping of clinically divergent p.Phe508del homozygous monozygous cystic fibrosis twins
References
J Cyst Fibros. 2020 Jun 13;S1569-1993(20)30754-2. doi: 10.1016/j.jcf.2020.06.009.
Title: Tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for minimal function CFTR mutations
References
J Cyst Fibros . 2020 Jun 13;S1569-1993(20)30128-4. doi: 10.1016/j.jcf.2020.04.015.

June 2020

Title: Defective BACH1/HO-1 regulatory circuits in cystic fibrosis bronchial epithelial cells
References
J Cyst Fibros . 2020 Jun 11;S1569-1993(20)30150-8. doi: 10.1016/j.jcf.2020.05.006. Online ahead of print.
Title: Accumulation and persistence of Ivacaftor in airway epithelia with prolonged treatment
References
J Cyst Fibros . 2020 Jun 11;S1569-1993(20)30123-5. doi: 10.1016/j.jcf.2020.04.010.

June 2020

Title: Clinimetric evaluation of muscle function tests for individuals with cystic fibrosis: A systematic review
References
J Cyst Fibros . 2020 Jun 10;S1569-1993(20)30164-8. doi: 10.1016/j.jcf.2020.05.014.

June 2020

Title: Building global development strategies for cf therapeutics during a transitional cftr modulator era
References
J Cyst Fibros . 2020 Jun 7;S1569-1993(20)30161-2. doi: 10.1016/j.jcf.2020.05.011. Online ahead of print.

June 2020

Title: Pseudomonas aeruginosa antimicrobial susceptibility test (AST) results and pulmonary exacerbation treatment responses in cystic fibrosis
References
J Cyst Fibros . 2020 Jun 4;S1569-1993(20)30152-1. doi: 10.1016/j.jcf.2020.05.008

June 2020

Title: Clinical effects of the three CFTR potentiator treatments curcumin, genistein and ivacaftor in patients with the CFTR-S1251N gating mutation
References
J Cyst Fibros. 2020 Jun 1;S1569-1993(20)30127-2. doi: 10.1016/j.jcf.2020.04.014. Online ahead of print.

May 2020

Title: A longitudinal assessment of non-Invasive biomarkers to diagnose and predict Ccystic Fibrosis-Associated Liver Disease
References
J Cyst Fibros . 2020 May 30;S1569-1993(20)30133-8. doi: 10.1016/j.jcf.2020.05.002.
Title: Disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate lyase enhances pathogen eradication by antibiotics
References
J Cyst Fibros . 2020 May 30;S1569-1993(20)30119-3. doi: 10.1016/j.jcf.2020.04.006.
 
Title: Metabolomics profiling of tobacco exposure in children with cystic fibrosis
References
J Cyst Fibros . 2020 May 30;S1569-1993(20)30134-X. doi: 10.1016/j.jcf.2020.05.003.

May 2020

Title: Circulating CRP and calprotectin to diagnose CF pulmonary exacerbations
References
J Cyst Fibros. 2020 May 28;S1569-1993(20)30129-6. doi: 10.1016/j.jcf.2020.04.016.

May 2020

Title: Testicular Pain Following Initiation of Elexacaftor/Tezacaftor/Ivacaftor in Males With Cystic Fibrosis
References
J Cyst Fibros. 2020 May 26;S1569-1993(20)30130-2. doi: 10.1016/j.jcf.2020.04.017

May 2020

Title: Global assessment of the integrated stress response in CF patient-derived airway and intestinal tissues
References
J Cyst Fibros. 2020 May 22;S1569-1993(20)30118-1. doi: 10.1016/j.jcf.2020.04.005.

May 2020

Title: Females with Cystic Fibrosis have a larger decrease in sweat chloride in response to lumacaftor/ivacaftor compared to males
References
J Cyst Fibros. 2020 May 21;S1569-1993(20)30135-1. doi: 10.1016/j.jcf.2020.05.004

May 2020

Title: Distal Intestinal Obstruction Syndrome resolved by dissolution with Coca-Cola® via colonoscopy in a cystic fibrosis patient
References
J Cyst Fibros . 2020 May 20;S1569-1993(20)30132-6. doi: 10.1016/j.jcf.2020.05.001. Online ahead of print. 

May 2020

Title: Glucose ingestion in cystic fibrosis induces severe redox imbalance: a potential role in diabetes
References
J Cyst Fibros. 2020 May;19(3):476-482. doi: 10.1016/j.jcf.2020.02.010. Epub 2020 Feb 27.
Title: Effect of one-year lumacaftor-ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients
References
J Cyst Fibros . 2020 Mar 19;S1569-1993(20)30073-4. doi: 10.1016/j.jcf.2020.03.002.

May 2020

Title: Average Rate of Lung Function Decline in Adults with Cystic Fibrosis in the United Kingdom: Data from the UK CF Registry
References
J Cyst Fibros. 2020 May 4;S1569-1993(20)30121-1. doi: 10.1016/j.jcf.2020.04.008.

April 2020

Title: A multinational report to characterise SARs-CoV-2 infection in people with cystic fibrosis
References
J Cyst Fibros. 2020 Apr 25;S1569-1993(20)30125-9. doi: 10.1016/j.jcf.2020.04.01

April 2020

Title: Use of a mobile application for self-management of pancreatic enzyme replacement therapy is associated with improved gastro-intestinal related quality of life in children with Cystic Fibrosis
References
J Cyst Fibros . 2020 Jul;19(4):562-568. doi: 10.1016/j.jcf.2020.04.001. Epub 2020 Apr 22

April 2020

Title: “Mild” CFTR genetic variants might be associated with a lower than expected probability of developing CF
References
J Cyst Fibros . 2020 Apr 20;S1569-1993(20)30098-9. doi: 10.1016/j.jcf.2020.03.019.

April 2020

Title: Resting energy expenditure in cystic fibrosis patients decreases after lung transplantation, which improves applicability of prediction equations for energy requirement
References
J Cyst Fibros. 2020 Apr 11. pii: S1569-1993(20)30092-8. doi: 10.1016/j.jcf.2020.03.013. 

April 2020

Title: Caring for gender diverse youth with cystic fibrosis
References
J Cyst Fibros. 2020 Apr 5;S1569-1993(20)30074-6. doi: 10.1016/j.jcf.2020.03.003.

March 2020

Title: Antibiofilm and mucolytic action of nitric oxide delivered as a gas or via macromolecular donor using in vitro and ex vivo models
References
J Cyst Fibros. 2020 Mar 20;S1569-1993(20)30075-8. doi: 10.1016/j.jcf.2020.03.004
Title: Go for It, Dream Big, Work Hard and Persist': A Message to the Next Generation of CF Leaders in Recognition of International Women's Day 2020
References
J Cyst Fibros. 2020 Mar 7;S1569-1993(20)30070-9. doi: 10.1016/j.jcf.2020.02.021.

March 2020

Title: Total bacterial load, inflammation, and structural lung disease in paediatric cystic fibrosis
References

J Cyst Fibros. 2020 Mar 18; - DOI: 10.1016/j.jcf.2020.03.008